The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

48 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Inhibition of O-GlcNAcase (OGA): A Potential Therapeutic Target to Treat Alzheimer's Disease.EBI
Therachem Research Medilab (India)
Elevation of cellular O-GlcNAcylation level by a potent and selective O-GlcNAcase inhibitor based on tetrahydroimidazopyridine scaffold.EBI
Nankai University
N-Acetylhexosaminidase inhibitory properties of C-1 homologated GlcNAc- and GalNAc-thiazolines.EBI
The State University of New Jersey
OGA inhibition by GlcNAc-selenazoline.EBI
Daegu University
A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo.EBI
Simon Fraser University
Structure-based discovery and development of novel O-GlcNAcase inhibitors for the treatment of Alzheimer's disease.EBI
Chonnam National University
Nanomolar inhibition of human OGA by 2-acetamido-2-deoxy-d-glucono-1,5-lactone semicarbazone derivatives.EBI
University of Debrecen
Benzo[d]thiazol-5-yl Compounds as O-GlcNAcase Inhibitors for Treating Alzheimer's Disease.EBI
Smith, Gambrell & Russell
Discovery of a Novel and Brain-Penetrant EBI
Takeda Pharmaceutical
Diazaspirononane Nonsaccharide Inhibitors of O-GlcNAcase (OGA) for the Treatment of Neurodegenerative Disorders.EBI
Janssen-Cilag
AcEBI
Nankai University
Discovery of MK-8719, a Potent O-GlcNAcase Inhibitor as a Potential Treatment for Tauopathies.EBI
Merck
Diazaspirononane Inhibitors of O-GlcNAc Hydrolase for the Treatment of Central Nervous System Diseases.EBI
Drexel University
Modification of the Thioglycosyl-Naphthalimides as Potent and Selective Human O-GlcNAcase Inhibitors.EBI
China Agricultural University
Sugar Kick Prevents Memory Impairment.EBI
TBA
Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents.EBI
Universit£
Interrogating the Roles of Post-Translational Modifications of Non-Histone Proteins.EBI
Temple University
Selective inhibition of ?-N-acetylhexosaminidases by thioglycosyl-naphthalimide hybrid molecules.EBI
Dalian University of Technology
Effects of novel human cathepsin S inhibitors on cell migration in human cancer cells.BDB
National Tsing Hua University
Ligand structure-activity requirements and phospholipid dependence for the binding of phorbol esters to protein kinase D.BDB
University of Pittsburgh
Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators.BDB
The Ohio State University
A new series of C3-aza carbocyclic influenza neuraminidase inhibitors: synthesis and inhibitory activity.BDB
Gilead Sciences
Quinolone-based HDAC inhibitors.BDB
Orchid Chemicals & Pharmaceuticals
Discovery of a novel class of potent HIV-1 protease inhibitors containing the (R)-(hydroxyethyl)urea isostere.BDB
Monsanto Corporate Research